Conclusions: CVF IL-6 could serve as a valid, non-invasive screening test for pregnant women to stratify risk for HCA, while a combination of AF, CVF, and plasma IL-6 could be a tractable diagnostic tool for clinicians, but large-scale Randomized Control Trials are needed to validate this hypothesis. Here, IL6 is linked to hepatocellular adenoma.